Direkt zum Inhalt

Schadendorf, D. ; Hauschild, A. ; Ugurel, S. ; Thoelke, A. ; Egberts, F. ; Kreissig, M. ; Linse, R. ; Trefzer, U. ; Vogt, T. ; Tilgen, W. ; Mohr, P. ; Garbe, C.

Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study

Schadendorf, D., Hauschild, A., Ugurel, S., Thoelke, A., Egberts, F., Kreissig, M., Linse, R., Trefzer, U., Vogt, T., Tilgen, W., Mohr, P. and Garbe, C. (2006) Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study. Annals of Oncology 17 (10), pp. 1592-1597.

Date of publication of this fulltext: 19 Dec 2024 14:32
Article



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleAnnals of Oncology
Publisher:OXFORD UNIV PRESS
Place of Publication:OXFORD
Volume:17
Number of Issue or Book Chapter:10
Page Range:pp. 1592-1597
Date2006
InstitutionsMedicine > Lehrstuhl für Dermatologie und Venerologie
Identification Number
ValueType
10.1093/annonc/mdl148DOI
KeywordsCEREBRAL METASTASES; AGGRESSIVE TREATMENT; CLINICAL-TRIALS; RADIOTHERAPY; MULTICENTER; IRRADIATION; FOTEMUSTINE; THERAPY; TUMORS; temozolomide; brain metastases; metastatic melanoma
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID69744

Export bibliographical data

Owner only: item control page

nach oben